Skip to Main Content

Author Details

Sook Wah Yee
University of California San Francisco
2001
103
39
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37474759Cardiac contraction and relaxation are regulated by distinct subcellular cAMP pools.Nat Chem Biol2024
36525397Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP).Diabetes2023
38076949<i>SLCO1B1</i> functional variants and statin-induced myopathy in people with recent genealogical ancestors from Africa: a population-based real-world study.medRxiv2023
37623829The Impacts of Slc19a3 Deletion and Intestinal SLC19A3 Insertion on Thiamine Distribution and Brain Metabolism in the Mouse.Metabolites2023
37657924TICBase: Integrated Resource for Data on Drug and Environmental Chemical Interactions with Mammalian Drug Transporters.Clin Pharmacol Ther2023
37790518Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates.Res Sq2023
37609337Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates.bioRxiv2023
37873173Structural and molecular basis of choline uptake into the brain by FLVCR2.bioRxiv2023
37151050The Effect of Trimethoprim on Thiamine Absorption: A Transporter-Mediated Drug-Nutrient Interaction.Clin Pharmacol Ther2023
37333090The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics.bioRxiv2023
37198956Characterization of P-glycoprotein orthologs from human, sheep, pig, dog, and cat.J Vet Pharmacol Ther2023
35089508High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3.Pharm Res2022
35349657Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682.Diabetes Care2022
35488474New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium.Clin Pharmacol Ther2022
35152405The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.Clin Pharmacol Ther2022
34185318Genomewide Association Studies in Pharmacogenomics.Clin Pharmacol Ther2021
33649974The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2.AAPS J2021
33759449Drugs in COVID-19 Clinical Trials: Predicting Transporter-Mediated Drug-Drug Interactions Using In Vitro Assays and Real-World Data.Clin Pharmacol Ther2021
34921098Emerging Roles of the Human Solute Carrier 22 Family.Drug Metab Dispos2021
34607834Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.Diabetes Care2021
32784450Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.Pharmaceuticals (Basel)2020
31774556Expanding Precompetitive Multisector Collaborations to Advance Drug Development and Pharmacogenomics.Clin Pharmacol Ther2020
33124720Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies.FASEB J2020
30474919Unveiling the Genetic Architecture of Human Disease for Precision Medicine.Clin Transl Sci2019
31553721Unraveling the functional role of the orphan solute carrier, SLC22A24 in the transport of steroid conjugates through metabolomic and genome-wide association studies.PLoS Genet2019
30924126Genome-Wide Association and Functional Studies Reveal Novel Pharmacological Mechanisms for Allopurinol.Clin Pharmacol Ther2019
30950137Functional and structural analysis of rare SLC2A2 variants associated with Fanconi-Bickel syndrome and metabolic traits.Hum Mutat2019
30982223Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers.Clin Transl Sci2019
30653498Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue.PLoS Biol2019
29650774Genetic Variants in <i>CPA6</i> and <i>PRPF31</i> Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes.Diabetes2018
29801583Pharmacogenetics of Antidiabetic Drugs.Adv Pharmacol2018
30125649Analytical considerations for measuring the globule size distribution of cyclosporine ophthalmic emulsions.Int J Pharm2018
30091177Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.Clin Pharmacol Ther2018
29720497Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity.Mol Pharmacol2018
29659562Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content.PLoS Biol2018
29679469Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.Clin Pharmacol Ther2018
26856248Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines.Pharmacogenomics J2017
28230985Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).J Med Chem2017
28562037Computational Discovery and Experimental Validation of Inhibitors of the Human Intestinal Transporter OATP2B1.J Chem Inf Model2017
28795399New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine.Clin Pharmacol Ther2017
27859023Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.Clin Pharmacol Ther2017
27885282Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine.Nat Rev Drug Discov2017
27001529Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy.Int J Pharm2016
26597253The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin.Clin Pharmacokinet2016
27902686Genomic Characterization of Metformin Hepatic Response.PLoS Genet2016
27500523Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.Nat Genet2016
27447836Metabolomic and Genome-wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1.Clin Pharmacol Ther2016
27415606A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin.Clin Pharmacol Ther2016
27378919Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans.Front Pharmacol2016
27256705Genomewide Association Studies in Pharmacogenomics: Meeting Report of the NIH Pharmacogenomics Research Network-RIKEN (PGRN-RIKEN) Collaboration.Clin Pharmacol Ther2016
  • 1 - 50 of 103

Recommended Authors

Chulalongkorn University
Career Start Year 2013
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2009
Number of shared co-authors 19
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 23
Federal Institute for Drugs and Medical Devices (BfArM)
Career Start Year 2008
Number of shared co-authors 1
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
Career Start Year 2007
Number of shared co-authors 6
The Ohio State University
Career Start Year 2005
Number of shared co-authors 6
University of Maryland School of Medicine
Career Start Year 2004
Number of shared co-authors 23
Genentech Inc.
Career Start Year 2003
Number of shared co-authors 14
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2003
Number of shared co-authors 0
Clinical Development
Career Start Year 2003
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
National Institutes of Health
Career Start Year 2002
Number of shared co-authors 24
Harbin Medical University
Career Start Year 2002
Number of shared co-authors 5
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 6
Stanford University
Career Start Year 2000
Number of shared co-authors 28
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 23
Center for Pharmacogenomics and Precision Medicine, University of Florida
Career Start Year 1998
Number of shared co-authors 25
Children's Hospital Oakland Research Institute
Career Start Year 1998
Number of shared co-authors 15
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year 1998
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 4
University of California
Career Start Year 1996
Number of shared co-authors 1
Syntimmune Inc.
Career Start Year 1995
Number of shared co-authors 0
and University of Tuebingen, University of Tuebingen
Career Start Year 1995
Number of shared co-authors 6
National Center for Toxicological Research
Career Start Year 1992
Number of shared co-authors 0
Marshall University, Joan C. Edwards School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Department of Pharmacotherapy and Translational Research, University of Florida
Career Start Year 1992
Number of shared co-authors 38
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 7
St. George's University Medical School
Career Start Year 1990
Number of shared co-authors 5
Department of Pharmaceutics, University of Florida
Career Start Year 1979
Number of shared co-authors 15

Collaborators

University of California San Francisco
Co-authored papers 82
University of California San Francisco
Co-authored papers 13
Co-authored papers 12
Tsinghua University
Co-authored papers 11
University of California san francisco
Co-authored papers 10
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 10
Department of Drug Metabolism and Pharmacokinetics, Inc.
Co-authored papers 9
University of California San Francisco
Co-authored papers 9
Gilead Sciences Inc.
Co-authored papers 9
Center for Visualization, Washington State University
Co-authored papers 8
University of California San Francisco
Co-authored papers 8
Victor Chang Cardiac Research Institute
Co-authored papers 7
Stanford University School of Medicine
Co-authored papers 7
Department of Pharmacy and Science for Life Laboratory, Uppsala University
Co-authored papers 7
Cardiovascular Research Institute, University of California San Francisco
Co-authored papers 7
Co-authored papers 7
Vanderbilt University Medical Center
Co-authored papers 7
University of California San Francisco
Co-authored papers 6
University of California San Francisco
Co-authored papers 6
Stanford University
Co-authored papers 6
Schools of Pharmacy and Medicine, University of California san francisco
Co-authored papers 5
Schools of Pharmacy and Medicine, University of California san francisco
Co-authored papers 5
University of Gothenburg
Co-authored papers 5
College of Medicine, Ewha Womans University
Co-authored papers 5
University of California san francisco
Co-authored papers 5
Amunix Pharmaceuticals
Co-authored papers 4
Departments of Pharmaceutical Sciences.
Co-authored papers 4
Co-authored papers 4
University of California san francisco
Co-authored papers 4
Collegeville
Co-authored papers 4